Tag: Rosacea

Fractionated Carbon Dioxide Laser Resurfacing as an Ideal Treatment Option for Severe Rhinophyma: A Case Report and Discussion

Fractionated Carbon Dioxide Laser Resurfacing as an Ideal Treatment Option for Severe Rhinophyma: A Case Report and Discussion

| January 1, 2019

 J Clin Aesthet Dermatol. 2019;12(1):24–27 by Victoria Comeau DO, PGY II; Marcus Goodman, DO; Mary Margaret Kober, MD; and Christopher Buckley, DO Drs. Comeau, Goodman, and Buckley are with the Department of Dermatology at Philadelphia College of Osteopathic Medicine in Roswell, Georgia. Drs. Goodman, Kober, and Buckley are also with Goodman Dermatology in Roswell, Georgia.  […]

Continue Reading

A Novel Night Moisturizer Enhances Cutaneous Barrier Function in Dry Skin and Improves Dermatological Outcomes in Rosacea-prone Skin

A Novel Night Moisturizer Enhances Cutaneous Barrier Function in Dry Skin and Improves Dermatological Outcomes in Rosacea-prone Skin

| December 1, 2018

J Clin Aesthet Dermatol. 2018;11(12):11–17 by Francine Santoro, MD, and Sandrine Teissedre, MSc Dr. Santoro is with Galderma Research and Development in Egerkingen, Switzerland. Dr. Teissedre is with Galderma Research and Development in Sophia Antipolis, France. FUNDING: This study was funded by Galderma Spirig. Medical writing and editorial support, provided by Mark Greener on behalf […]

Continue Reading

MauiDerm for Dermatologists: Selected Abstracts from the 2018 Meeting

MauiDerm for Dermatologists: Selected Abstracts from the 2018 Meeting

| May 1, 2018

Click to view the e-Edition of this supplement A Message from the Guest Editor and MauiDerm Program Director Dear Colleagues: The 2018 edition of the MauiDerm for Dermatologists meeting had a wide variety of clinical and scientific data presented not only at the podium, but in its poster sessions as well. A wide range of […]

Continue Reading

Quality of Life in Individuals with Erythematotelangiectatic and Papulopustular Rosacea: Findings From a Web-based Survey

Quality of Life in Individuals with Erythematotelangiectatic and Papulopustular Rosacea: Findings From a Web-based Survey

| February 1, 2018

by Joshua A. Zeichner, MD; Lawrence F. Eichenfield, MD; Steven R. Feldman, MD, PhD; J. Scott Kasteler, MD; and Ilia L. Ferrusi, PhD Dr. Zeichner is with Mount Sinai Hospital in New York, New York. Dr. Eichenfield is with the University of California and Rady Children’s Hospital, both in San Diego, California. Dr. Feldman is with […]

Continue Reading

Topical Ivermectin: Data Supporting Dual Modes of Action in Rosacea

Topical Ivermectin: Data Supporting Dual Modes of Action in Rosacea

| September 1, 2017

by James Q. Del Rosso, DO, FAOCD, FAAD Dr. Del Rosso is Research Director at JDR Dermatology Research in Las Vegas, Nevada; Adjunct Clinical Professor of Dermatology at Touro University Nevada, Las Vegas; and with Dermatology and Cutaneous Surgery at Thomas Dermatology in Las Vegas, Nevada. Funding: The author did not receive any form of […]

Continue Reading

Topical Alpha-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now?

Topical Alpha-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now?

| July 1, 2017

by James Q. Del Rosso, DO, FAOCD, FAAD Dr. Del Rosso is Research Director at JDR Dermatology Research, Las Vegas, Nevada and at Henderson Dermatology Research in Henderson, Nevada; is Adjunct Clinical Professor (Dermatology) at ableouro University Nevada, Las Vegas, Nevada; and practices Dermatology and Cutaneous Surgery at Thomas Dermatology in Las Vegas, Nevada. J […]

Continue Reading

Management of Papulopustular Rosacea and Perioral Dermatitis with Emphasis on Iatrogenic Causation or Exacerbation of Inflammatory Facial Dermatoses Use of Doxycycline-modified Release 40mg Capsule Once Daily in Combination with Properly Selected Skin Care as an Effective Therapeutic Approach

Management of Papulopustular Rosacea and Perioral Dermatitis with Emphasis on Iatrogenic Causation or Exacerbation of Inflammatory Facial Dermatoses Use of Doxycycline-modified Release 40mg Capsule Once Daily in Combination with Properly Selected Skin Care as an Effective Therapeutic Approach

| August 18, 2011 | 0 Comments

James Q. Del Rosso, DO, FAOCD Dermatology Residency Program Director, Valley Hospital Medical Center, Las Vegas, Nevada; Clinical Professor (Dermatology), Touro University College of Osteopathic Medicine, Henderson, Nevada; and Private Practice, Dermatology and Cutaneous Surgery, Las Vegas Skin & Cancer Clinics, Las Vegas, Nevada and Henderson, Nevada

Continue Reading